Breckenridge Pharmaceutical, Inc. recalls
7 recalls filed under Breckenridge Pharmaceutical, Inc.. The most recent was published June 17, 2026.
-
Class II · 4 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP recall: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
-
Class II · 4 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP, 60mg recall: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
-
Class II · 6 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules USP, 60mg recall: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
-
Class II · 11 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP recall: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
-
Class II · 11 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP recall: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
-
Class II · 12 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP, 60 mg recall: CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment
CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
-
Class II · 1+ years ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP, 30 mg, 1 recall: CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.
About this page
Breckenridge Pharmaceutical, Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.